In summary, here we demonstrate that curcumin down-regulates DNMT1 expression, which results in DNA hypomethylation and reactivation of TSGs in AML, and also correlates to its role as an inhibitor of tumor growth, both in vitro and in vivo. The gene discussed is DNMT1; the disease is acute myeloid leukemia.